| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/06/2011 | US20110003711 Cell lines expressing gaba receptor and methods using them |
| 01/06/2011 | US20110003697 Plant myb transcription factor homologs |
| 01/06/2011 | US20110003399 Tumor Necrosis Factor-Gamma |
| 01/06/2011 | US20110003390 Method and device for cell culture in open continuous mode |
| 01/06/2011 | US20110003389 Cell culture instrument and cell culture method using the same |
| 01/06/2011 | US20110003388 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 01/06/2011 | US20110003387 Method of producing erythrocytes without feeder cells |
| 01/06/2011 | US20110003386 Identification and characterization of cancer stem cells and methods of use |
| 01/06/2011 | US20110003385 Regulated transcription of targeted genes and other biological events |
| 01/06/2011 | US20110003384 Compositions and methods of use for mgd-csf in disease treatment |
| 01/06/2011 | US20110003383 Antibodies to ht5gj57 |
| 01/06/2011 | US20110003381 Viral vectors and host cells and methods of making and using them |
| 01/06/2011 | US20110003380 Sample Processing System and Methods |
| 01/06/2011 | US20110003365 Method of preparing induced pluripotent stem cells deprived of reprogramming gene |
| 01/06/2011 | US20110003362 Conjugates of biological substances |
| 01/06/2011 | US20110003361 Novel fructosyl peptide oxidase |
| 01/06/2011 | US20110003360 Delta-6 desaturase and uses thereof |
| 01/06/2011 | US20110003358 Cultures of gfap+ nestin+ cells that differentiate to neurons |
| 01/06/2011 | US20110003351 Delta-5 desaturase and uses thereof |
| 01/06/2011 | US20110003340 Synthetic genes for plant gums and other hydroxyproline-rich proteins |
| 01/06/2011 | US20110003339 Pathogenic Escherichia Coli Associated Protein |
| 01/06/2011 | US20110003338 Antibodies with enhanced adcc function |
| 01/06/2011 | US20110003334 Method for producing a cell capable of high-yield production of heteroproteins |
| 01/06/2011 | US20110003332 Recombinantly modified plasmin |
| 01/06/2011 | US20110003327 Methods for production of atrial progenitors and their differentiation into smooth muscle cells and cardiomyocytes |
| 01/06/2011 | US20110003319 Transgenic Trasnchromosomal Rodents for Making Human Antibodies |
| 01/06/2011 | US20110003315 Chimeric pcsk9 proteins, cells comprising same, and assays using same |
| 01/06/2011 | US20110003303 Sheath flow devices and methods |
| 01/06/2011 | US20110003276 Blood separation and concentration system |
| 01/06/2011 | US20110003008 Mesenchymal stem cell particles |
| 01/06/2011 | US20110003003 Magnetic cells for localizing delivery and tissue repair |
| 01/06/2011 | US20110002983 Compound |
| 01/06/2011 | US20110002955 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 01/06/2011 | US20110002954 Rhoc-based immunotherapy |
| 01/06/2011 | US20110002951 Modified Leukotoxin Gene and Protein |
| 01/06/2011 | US20110002950 Pig edema disease vaccine |
| 01/06/2011 | US20110002946 Immunostimulatory Combinations |
| 01/06/2011 | US20110002944 Compositions and Methods to Promote Neural Cell Growth |
| 01/06/2011 | US20110002942 Engineered Anti-IL-23 Antibodies |
| 01/06/2011 | US20110002938 Hematopoietic cells expressing the protein krtcap3 and ligands for the protein krtcap3 |
| 01/06/2011 | US20110002937 Method of making hybrid cells that express useful antibodies |
| 01/06/2011 | US20110002934 Uses of anti-cd40 antibodies |
| 01/06/2011 | US20110002933 Dr4 antibodies and uses thereof |
| 01/06/2011 | US20110002932 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF |
| 01/06/2011 | US20110002929 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
| 01/06/2011 | US20110002927 Antigen-binding polypeptides against cartilage degeneration |
| 01/06/2011 | US20110002926 Hepatitis c virus antibodies |
| 01/06/2011 | US20110002914 Hybrid tetnus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 01/06/2011 | US20110002913 Use of interleukin-4 antagonists and compositions thereof |
| 01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
| 01/06/2011 | US20110002907 Methods, Systems, Compositions And Dosage Forms For Diagnosing And Treating Male Infertility |
| 01/06/2011 | US20110002904 Synovial villi for use with tissue engineering |
| 01/06/2011 | US20110002903 Immunogenic control of tumours and tumour cells |
| 01/06/2011 | US20110002899 Lymph Nodes as a Site for Regeneration |
| 01/06/2011 | US20110002897 Directed differentiation of stem cells |
| 01/06/2011 | US20110002895 Composition for autotransplantation or allotransplantation using dental pulp stem cell, and use of the composition |
| 01/06/2011 | US20110002892 Modular aptamar-regulated ribozymes |
| 01/06/2011 | US20110002888 Albumin Fusion Proteins |
| 01/06/2011 | US20110002887 Combinations of antibodies selective for dr5 and other therapeutic agents |
| 01/06/2011 | US20110002885 Methods of using isolated recombinant polypeptide antagonists of sdf-1 |
| 01/06/2011 | CA2767014A1 Method of producing erythrocytes without feeder cells |
| 01/06/2011 | CA2766770A1 Novel antibodies and their uses in therapeutic and diagnostic methods |
| 01/06/2011 | CA2766250A1 Blood component separation system and separation material |
| 01/06/2011 | CA2766018A1 Maltotriosyl transferase, process for production thereof, and use thereof |
| 01/06/2011 | CA2765558A1 Bioassay method for antibody against thyroid-stimulating hormone receptor, measurement kit for the antibody, and novel genetically modified cell for use in the bioassay method orthe measurement kit |
| 01/05/2011 | EP2270504A2 Techniques for growth and differentiation of human pluripotent stem cells |
| 01/05/2011 | EP2270196A2 Assay for drug discovery based on in vitro differentiated cells |
| 01/05/2011 | EP2270183A2 Down-regulation of gene expression using artificial microRNAs |
| 01/05/2011 | EP2270182A2 DSRNA as insect control agent |
| 01/05/2011 | EP2270181A2 DSRNA as insect control agent |
| 01/05/2011 | EP2270171A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 01/05/2011 | EP2270170A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/05/2011 | EP2270168A1 Mutant gene capable of controlling the oil-and-fat content in seed, and method for controlling the oil-and-fat content in seed |
| 01/05/2011 | EP2270164A2 Recombinant protein variants |
| 01/05/2011 | EP2270152A1 Expression system using mammalian beta-actin promoter |
| 01/05/2011 | EP2270146A1 Method of inducing differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene |
| 01/05/2011 | EP2270137A1 Method for producing cells having characteristic of hematopoietic stem cells/progenitor cells |
| 01/05/2011 | EP2270054A2 Anti-idiotype antibodies of the human monoclonal antibody SC-1, and their production and use |
| 01/05/2011 | EP2270051A2 Antibody specific for human PD-1 and CD3 |
| 01/05/2011 | EP2270047A2 Anti-C5 antibodies and their therapeutic uses |
| 01/05/2011 | EP2270046A2 Methods and compositions for the treatment of hemolysis-associated diseases |
| 01/05/2011 | EP2270045A1 Antibodies against Clostridium difficile toxins and uses thereof |
| 01/05/2011 | EP2270042A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270041A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2269648A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
| 01/05/2011 | EP2269647A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
| 01/05/2011 | EP2269634A2 Antigenic polypeptides |
| 01/05/2011 | EP2269629A2 Compositions and methods for producing antigen-presenting cells |
| 01/05/2011 | EP2269628A2 Pancreas-specific proteins |
| 01/05/2011 | EP2269619A1 Methods and compositions concerning poxviruses and cancer |
| 01/05/2011 | EP2269618A1 An oncolytic vaccinia virus for use in combination with a chemotherapy for treating cancer. |
| 01/05/2011 | EP2269617A1 Process for enriching a population of sperm cells |
| 01/05/2011 | EP2269616A2 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 01/05/2011 | EP2269444A2 DSRNA as insect control agent |
| 01/05/2011 | EP2268815A1 New mutated hydroxyphenylpyruvate dioxygenase, dna sequence and isolation of plants which are tolerant to hppd inhibitor herbicides |
| 01/05/2011 | EP2268814A1 Compositions and methods related to silicon transport |
| 01/05/2011 | EP2268809A1 Method of nuclear reprogramming |
| 01/05/2011 | EP2268798A1 Method for obtaining ngn3-expressing cells and insulin producing-beta cells |
| 01/05/2011 | EP2268797A1 Motor neurons developed from stem cells |
| 01/05/2011 | EP2268796A1 Vectors and methods for generating vector-free induced pluripotent stem (ips) cells using site-specific recombination |